Muhammad Usman Rashid

Author

Shaukat Khanum Memorial Cancer Hospital and Research Center ORCID

Also Known As

Alpa V. Patel, Beatrice Melin, Brigitte Rack, Catherine M. Phelan, Darya Prokofyeva, Diana Torres, Dijana Plaseska-Karanfilska, Elizabeth M. Poole, Georg Pfeiler, Johanna Rantala

130

Publications

4.2K

Citations

H-Index

Concepts

All Affiliations

Shaukat Khanum Memorial Cancer Hospital and Research Center German Cancer Research Center Heidelberg University Levine Cancer Institute DKFZ-ZMBH Alliance

About

Muhammad Usman Rashid is an author at Shaukat Khanum Memorial Cancer Hospital and Research Center specializing in medicine, cancer genetics, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	319
2	Public Health	1	1	50
3	Biostatistics	1	1	19
4	Gastroenterology	1	1	19
5	Molecular Genetics	1	1	14

Muhammad Usman Rashid

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Pathology of Breast and Ovarian Cancers among <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: Results from the Consortium of Investigators of Modifiers of <i>BRCA1</i> / <i>2</i> (CIMBA) Nasim Mavaddat, Daniel Barrowdale, Irene L. Andrulis, Cancer Epidemiology Biomarkers & Prevention	2012	649
Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian Cancer Timothy R. Rebbeck, Nandita Mitra, Fei Wan, JAMA	2015	484
Prevalence of <i>BRCA1</i> and <i>BRCA2</i> mutations in Pakistani breast and ovarian cancer patients Muhammad Usman Rashid, Anbreen Zaidi, Diana Torres, International Journal of Cancer	2006	119
Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia Amanda B. Spurdle, Fergus J. Couch, Michael T. Parsons, Breast Cancer Research	2014	119
High proportion of BRCA1/2 founder mutations in Hispanic breast/ovarian cancer families from Colombia Diana Torres, Muhammad Usman Rashid, Fabián Gil, Breast Cancer Research and Treatment High ProportionBrca1/2 Founder MutationsBreast OncologySomatic VariantGenetics	2006	106
<i>BRCA2</i> Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer Hermela Shimelis, Romy L.S. Mesman, Catharina Von Nicolai, Cancer Research	2017	90
Current Status of the Management of Hereditary Breast and Ovarian Cancer in Asia: First Report by the Asian BRCA Consortium Seigo Nakamura, Ava Kwong, Sung-Won Kim, Public Health Genomics	2015	55
Family History, Genetic Testing, and Clinical Risk Prediction: Pooled Analysis of CHEK2*1100delC in 1,828 Bilateral Breast Cancers and 7,030 Controls Olivia Fletcher, Nichola Johnson, Isabel dos‐Santos‐Silva, Cancer Epidemiology Biomarkers & Prevention	2009	55
Association between the BsmI Polymorphism in the Vitamin D Receptor Gene and Breast Cancer Risk: Results from a Pakistani Case-Control Study Muhammad Usman Rashid, Merium Muzaffar, Faiz Ali Khan, PLoS ONE	2015	50
Prevalence and Penetrance of BRCA1 and BRCA2 Germline Mutations in Colombian Breast Cancer Patients Diana Torres, J Lorenzo Bermejo, Muhammad Usman Rashid, Scientific Reports Brca1 MutationSomatic VariantCancer EpidemiologyCancer RiskBreast Oncology	2017	50

Page 1